Reductions in OFF Time with ND0612 For Patients with Parkinson's Disease Experiencing Motor Fluctuations: Responder-Analysis from an Open-Label Phase 2 Study

被引：0
|
作者：
Ellenbogen, A.
Espay, A.
Isaacson, S.
Lopes, N.
Sasson, N.
Yardeni, T.
Poewe, W.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
46
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [41] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease
    Hattori, Nobutaka
    Takeda, Atsushi
    Takeda, Shinichi
    Nishimura, Akira
    Kitagawa, Tadayuki
    Mochizuki, Hideki
    Nagai, Masahiro
    Takahashi, Ryosuke
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (03) : 299 - 308
  • [42] Long-term safety and efficacy of apomorphine infusion in Parkinson's disease (PD) patients with persistent motor fluctuations: results of the 1-year open-label phase of the TOLEDO study
    Katzenschlager, R.
    Poewe, W.
    Rascol, O.
    Trenkwalder, C.
    Deuschl, G.
    Chaudhuri, K.
    Henriksen, T.
    van Laar, T.
    Lockhart, D.
    Lees, A.
    MOVEMENT DISORDERS, 2019, 34 : S52 - S53
  • [43] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
    Nobutaka Hattori
    Atsushi Takeda
    Shinichi Takeda
    Akira Nishimura
    Tadayuki Kitagawa
    Hideki Mochizuki
    Masahiro Nagai
    Ryosuke Takahashi
    Journal of Neural Transmission, 2019, 126 : 299 - 308
  • [44] INTERIM RESULTS FROM AN ONGOING, LONG-TERM, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN PATIENTS WITH PARKINSON'S DISEASE AND SEVERE MOTOR FLUCTUATIONS
    Odin, P.
    Chatamra, K.
    Espay, A. J.
    Standaert, D. G.
    Fernandez, H. H.
    Benesh, J.
    Robieson, W.
    Hass, S. L.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 241 - 241
  • [45] Levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations: Interim quality-of-life endpoints in an ongoing, open-label study
    Standaert, D. G.
    Fernandez, H. H.
    Odin, P.
    Hauser, R. A.
    Espay, A. J.
    Hass, S.
    Robieson, W. Z.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S140 - S140
  • [46] Interim results of quality-of-life endpoints of an open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations
    Standaert, D. G.
    Espay, A. J.
    Fernandez, H. H.
    Benesh, J.
    Lenz, R. A.
    Pritchett, Y. L.
    Hass, S.
    Chatamra, K.
    MOVEMENT DISORDERS, 2011, 26 : S141 - S142
  • [47] Early Onset of Efficacy During Titration in US Phase 3 Open-label InfusON Trial Of Apomorphine Subcutaneous Infusion for Parkinson's Disease Motor Fluctuations
    Isaacson, S.
    Ceresoli-Borroni, G.
    Espay, A.
    Pahwa, R.
    Agarwal, P.
    Shill, H.
    Hui, J.
    Dashtipour, K.
    Lew, M.
    Qin, P.
    LeWitt, P.
    MOVEMENT DISORDERS, 2023, 38 : S29 - S29
  • [48] A Phase 3 Study of Tozadenant (TOZ-PD) as a Maintenance Therapy for Patients With Parkinson's Disease Experiencing Motor Fluctuations: Characterization of Study Population
    Kieburtz, Karl
    Olanow, C. Warren
    Krishnaswami, Jayshree
    Resburg, Chris
    Kerwood, Fred
    Glass, Andrew
    Kenney, Christopher
    NEUROLOGY, 2018, 90
  • [49] Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson's disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial
    Chang, H. J.
    Park, J.
    Oh, S.
    Shin, C. W.
    Cho, J. W.
    Lee, J. Y.
    MOVEMENT DISORDERS, 2022, 37 : S321 - S321
  • [50] Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study
    Kassubek, Jan
    Factor, Stewart A.
    Balaguer, Ernest
    Schwarz, Johannes
    Chaudhuri, K. Ray
    Isaacson, Stuart H.
    Wu, Stacy
    Muhr, Carmen Denecke
    Kulisevsky, Jaime
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3554 - 3570
12345